Immune Checkpoint Blockade Therapy for Breast Cancer: Lessons from Epithelial-Mesenchymal Transition.

"Declarations FundingAnushka Dongre has received a research grant (K22 Transition Career Development Award 5K22CA255420) from the National Cancer Institute (NCI), National Institutes of Health (NIH). The open access fee was paid using start-up funds provided to Anushka Dongre by Cornell University. Conflict of interestAuthor Anushka Dongre has received a research grant from the National Cancer Institute (NCI), National Institutes of Health (NIH). Author Isabel O’Connell declares that they have no conflicts of interest that might be relevant to the contents of this article. Author contributionsIO and AD designed, planned, and wrote the manuscript. Ethics approvalNot applicable. Consent to participate and publicationNot applicable. Data availabilityNot applicable. Code availabilityNot applicable. Conflict of interest Author Anushka Dongre has received a research grant from the National Cancer Institute (NCI), National Institutes of Health (NIH). Author Isabel O’Connell declares that they have no conflicts of interest that might be relevant to the contents of this article."

"Funding Anushka Dongre has received a research grant (K22 Transition Career Development Award 5K22CA255420) from the National Cancer Institute (NCI), National Institutes of Health (NIH). The open access fee was paid using start-up funds provided to Anushka Dongre by Cornell University."